The aim of the opinion is to address the use of nanomaterials in medical devices and to provide information for risk assessors regarding specific aspects that need to be considered in the safety evaluation of nanomaterials.
In line with the Stakeholder Dialogue Procedures (Annex IV to the Rules of Procedures of the Scientific Committees), the SCENIHR is now seeking feedback from the scientific community and stakeholders on the risk assessment related to the ‘Guidance on the Determination of Potential Health Effects of Nanomaterials Used in Medical Devices’.
All interested parties are invited to submit written comments on the preliminary opinion by 03 October 2014 in view of gathering specific comments, suggestions, explanations or contributions on the scientific basis of the opinion, as well as any other scientific information regarding the questions addressed, to enable Scientific Committees to focus on issues which need to be further investigated.
The electronic template provided with the documents should be used exclusively for the submission of comments, with reference made to the line and page numbers. Please note that comments submitted by email or post cannot be taken into account.
As stated in the Rules of Procedures (Annex IV), a submission will not be considered if it is:
- submitted after the deadline set out in the call;
- presented in any form other than what is provided for in the instructions and template;
- not related to the contents of the document;
- contains complaints against institutions, personal accusations, irrelevant or offensive statements or material;
- is related to policy or risk management aspects, which is outside the scope of SCENIHR's activities.
The SCENIHR will assess all comments from interested parties which are submitted in line with the criteria above and taken into consideration, if found relevant.
All comments submitted may be published on the Scientific Committees' website. Please read the Privacy statement before submitting comments